A prospective evaluation of the role of transient elastography for the detection of hepatic fibrosis in type 2 diabetes without overt liver disease

References

• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–31.
   PubMed Web of Science ®Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413–19.
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44:865–73.
   PubMed Web of Science ®Google Scholar
• Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, Norris HT, Caro JF. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 1990;85:1349–55.
   PubMed Web of Science ®Google Scholar
• Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106–10.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004;2:262–5.
   PubMed Web of Science ®Google Scholar
• Cua IH, Hui JM, Kench JG, George J. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. Hepatology 2008;48:723–31.
   PubMed Web of Science ®Google Scholar
• Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165–73.
   PubMed Web of Science ®Google Scholar
• Van der Poorten D, Kwok A, Lam T, Ridley L, Jones DB, Ngu MC, Lee AU. Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital. Intern Med J 2006;36:692–9.
   Google Scholar
• Jacqueminet S, Lebray P, Morra R, Munteanu M, Devers L, Messous D, Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin Gastroenterol Hepatol 2008;6:828–31.
   PubMed Web of Science ®Google Scholar
• Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343–50.
   PubMed Web of Science ®Google Scholar
• Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960–74.
   PubMed Web of Science ®Google Scholar
• Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48–54.
   PubMed Web of Science ®Google Scholar
• Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis? J Hepatol 2011;54:64–71.
   PubMed Web of Science ®Google Scholar
• Marin JC, De La Cruz J, Fernandez I, Martin AM, Munoz R, Colina F, Soils JA. Prospective comparison between transient elastography (FibroScan), APRI and Forns test for assessing liver fibrosis in patients with histological features of NAFLD. J Hepatol 2007;46:S275.
   Google Scholar
• Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 2010;51:454–62.
   PubMed Web of Science ®Google Scholar
• Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008;40:371–8.
   PubMedGoogle Scholar
• Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005;51:1867–73.
   PubMed Web of Science ®Google Scholar
• Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S, Torella R, Persico M. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006;38:485–9.
   PubMedGoogle Scholar
• Schwenzer NF, Springer F, Schraml C, Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 2009;51:433–45.
   PubMed Web of Science ®Google Scholar
• Brunt EM, Janney CG, Di Bisceglie AM, Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467–74.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313–21.
   PubMed Web of Science ®Google Scholar
• Angulo P, Keach JC, Batts KP, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30:1356–62.
   PubMed Web of Science ®Google Scholar
• Leite NC, Villela-Nogueira CA, Pannain VL, Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int 2011;31:700–6.
   Google Scholar
• Castera L, Foucher J, Bernard PH, Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 2010;51:828–35.
   PubMed Web of Science ®Google Scholar
• Hodge A, Kemp W. Transient elastography: the bigger we are, the harder to scan. J Gastroenterol Hepatol 2011;26:217–19.
   Google Scholar
• UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.
   PubMed Web of Science ®Google Scholar
• Goessling W, Massaro JM, Vasan RS, Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008;135:1935–44; 1944 e1931.
   PubMed Web of Science ®Google Scholar